Comparison of performances between risk scores for predicting mortality at 30 days in patients with community acquired pneumonia-Reference-Cited by-同舟云学术

Comparison of performances between risk scores for predicting mortality at 30 days in patients with community acquired pneumonia

Published:2024-09-03 Issue:1 Volume:24 Page:
ISSN:1471-2334
Container-title:BMC Infectious Diseases
language:en
Short-container-title:BMC Infect Dis

Author:

Tuta-Quintero Eduardo,Goyes Alirio Rodrigo Bastidas^ORCID,Guerrón-Gómez Gabriela,Martínez María C.,Torres Daniela,Schloss Carolina,Camacho Julian,Bonilla Gabriela,Cepeda Daniela,Romero Paula,Fuentes Yuli,Garcia Esteban,Acosta David,Rodríguez Santiago,Alvarez David,Reyes Luis F.

Funder

Universidad de La Sabana

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1186/s12879-024-09792-1.pdf

Reference37 articles.

1. Gadsby NJ, Musher DM. The Microbial etiology of community-acquired pneumonia in adults: from classical bacteriology to Host Transcriptional Signatures. Clin Microbiol Rev. 2022;35(4):e0001522.

2. Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, et al. Diagnosis and treatment of adults with community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200(7):e45–67.

3. Nair GB, Niederman MS. Updates on community acquired pneumonia management in the ICU. Pharmacol Ther. 2021;217:107663.

4. File TM Jr, Ramirez JA. Community-Acquired Pneumonia. N Engl J Med. 2023;389(7):632–41.

5. Khari S, Salimi Akin Abadi A, Pazokian M, Yousefifard M. CURB-65, qSOFA, and SIRS Criteria in Predicting In-Hospital mortality of critically ill COVID-19 patients; a Prognostic Accuracy Study. Arch Acad Emerg Med. 2022;10(1):e36.